Babineaux-Fontenot Claire 4

What Happened

• Claire Babineaux-Fontenot, a director of Abbott Laboratories (ABT), received a grant of 2,286 restricted stock units (RSUs) on 2026-04-24. The grant was reported on a Form 4 filed 2026-04-28. The grant price/value is shown as $0.00 in the filing (typical for RSU awards when granted rather than sold).

Key Details

• Transaction date: 2026-04-24; Form 4 filed: 2026-04-28.
• Award: 2,286 RSUs; reported acquisition price: $0.00; reported dollar amount: $0.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: RSUs granted under the Abbott Laboratories 2026 Incentive Stock Program. The award will convert one-for-one into Abbott common shares upon the earlier of the director’s separation from service, death, or a change in control.
• No late-filing flag is indicated in the provided information.

Context

• This is a compensation award (A = Award/Grant), not an open-market purchase or sale. RSU grants are routine director compensation and do not by themselves indicate a buy/sell signal. The shares will be issued in the future if and when vesting/payment conditions are met (separation, death, or change in control).